I recently attended a symposium conducted by Western University of Health Sciences, College of Pharmacy entitled, Sterile Compounding New Laws And Regulations. This took place at the Newport Beach Hyatt on January 18 of this year, and it was truly rewarding. There were great speakers who had up-to-date information on the new laws – both state and federal – affecting sterile compounding.  David Miller, RPh, Executive Vice President of International Academy of Compounding Pharmacists, gave a great review of the Federal legislation (HR 3204) affecting sterile compounding pharmacies. He was able to define the various sections of 503A and 503B and how they impact current compounding pharmacy business models. Another great speaker was Amy Gutierrez, Chief Pharmacy Officer, for the Los Angeles County Department of Health Services.  She reviewed the NECC accident as well as other issues affecting patient health relating to compounding pharmacies. This event took place on a Saturday, but was well worth the time and the information gained through an update of how pharmacy laws are affecting our practice to ensure that the needs of the patients of our clients are met. To view the class overview, objectives, and speakers’ bios, please click here.